May 27, 2020
EC approves BMS’s Zeposia to treat patients with certain MS
Zeposia offers relapsing remitting multiple sclerosis (RRMS) patients with active disease in the European Union a new oral option to…
Pharmaceuticals, Biotechnology and Life Sciences
Zeposia offers relapsing remitting multiple sclerosis (RRMS) patients with active disease in the European Union a new oral option to…